GRBK (GRBK)

$2.7B
Market Cap
8.9
P/E Ratio
1.98
Beta
Dividend Yield
Piotroski 4/9Altman Z 5.9 SafeBeneish M -0.36 Flag (> −2.22)ROIC−WACC -1.1%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 5.9. Beneish M-Score of -0.36 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency for GRBK presents a structural challenge, evidenced by an ROIC of 14.6% that falls short of the estimated WACC of 15.7%, resulting in a negative spread of -1.1%. This indicates the firm is currently destroying shareholder value relative to its cost of capital despite maintaining healthy profitability metrics, including a net margin of 14.9% and gross margin of 30.5%. While the Piotroski F-Score of 4/9 suggests moderate financial strength with some weaknesses in balance sheet stability or earnings quality, the Altman Z-Score of 5.9 signals a low probability of bankruptcy distress. The Beneish M-Score of -0.36 further supports the absence of aggressive earnings manipulation, yet the stagnation in revenue growth at year-over-year zero complicates the sustainability of these margins without top-line expansion.

Valuation metrics reveal a significant divergence between current pricing and intrinsic value models. Trading at a P/E ratio of 8.9x, which appears compressed relative to typical industry multiples for profitable firms with positive cash flows, suggests the market is discounting future prospects heavily or anticipating further stagnation. However, this low multiple contrasts sharply with a DCF-derived fair value of $86, implying that current prices may be undervalued if growth assumptions align with base-case scenarios. The disconnect between the depressed valuation and the theoretical fair value highlights potential market overreaction to the lack of revenue momentum rather than fundamental insolvency, though the negative ROIC-WACC spread serves as a cautionary indicator regarding long-term compounding capabilities absent strategic improvement.

The risk-reward profile is nuanced by conflicting signals: while solvency risks appear minimal given the high Altman Z-Score and low Beneish M-Score, the core business model faces headwinds from flat revenue growth and capital returns that fail to cover the cost of equity. Investors must weigh whether the current P/E compression offers a margin of safety against the persistent drag on value creation indicated by the negative spread. The data does not suggest imminent distress but points to an asset whose economic engine is currently inefficient, requiring either operational leverage or multiple expansion to align realized returns with theoretical valuations.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →13.7%15.7%17.7%
2%$97$81$69
3%$105$86$72
4%$113$91$76

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=15.7%, terminal growth 3%. Fair value $86 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
5.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-0.36
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

30.5%
Gross Margin
14.9%
Net Margin
14.6%
ROIC
15.7%
WACC
ROIC − WACC Spread: -1.1%— Negative spread.
-0.0%
Revenue Growth (YoY)
-17.9%
Earnings Growth (YoY)
208.4M
Free Cash Flow
1%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.31x
Debt / Equity
7.36x
Current Ratio
0.3x
Net Debt / EBITDA
7.32%
FCF Yield
414.6M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $1.75
Act: $1.67
-4.8%
Q3
✗ Miss
Est: $1.94
Act: $1.85
-4.4%
Q2
✓ Beat
Est: $1.48
Act: $1.77
+20.0%
Q1
✓ Beat
Est: $1.67
Act: $1.78
+6.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.9
Forward P/E
PEG Ratio
1.49
Price/Book
220505
Avg Volume
$80.97
52W High
$50.57
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$57M
Tracked Passive Exposure
7
ETFs Holding GRBK
0.10%
Avg Weight in ETFs
$56B
Total ETF AUM

When investors buy or sell ETFs like XHB or SLYG, the fund manager is mechanically forced to buy or sell GRBK shares regardless of GRBK's individual fundamentals. We estimate $57M of passive capital is structurally linked to GRBK through 7 tracked ETFs. Passive flows have a limited but growing influence on GRBK's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in GRBK to visualize passive redemption contagion across ETFs and collateral stocks.

GRBK Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
GRBKEpicenterVTWOETFSPSMETFSPTMETFAMZNLow RiskTSLALow RiskHDLow RiskMODLow RiskMTHLow Risk
GRBK Price Drop (%)0

If GRBK (GRBK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with GRBK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

GRBK Ownership Dynamics

Ticker
GRBK

Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

GRBK Capital Efficiency

How efficiently does GRBK convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$208M
EBITDA
$415M
FCF Conversion
50%
Reinvestment Rate
50%
50% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
14.6%
ROIC − WACC Spread
-1.1%

GRBK converts 50% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-1.1%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14319$63.41$20,227.79
2026-05-13598$64.28$38,439.44
2026-05-1219$65.26$1,239.94
2026-05-08577$65.64$37,874.28
2026-04-28352$70.87$24,946.24
2026-04-16123$65.56$8,063.88
2026-04-13192$67.28$12,917.76
2026-03-313,998$62.75$250,874.5
2026-03-2068$62.93$4,279.24
2026-02-19772$79.35$61,258.2
2026-02-042,305$72.50$167,112.5
2026-01-201,079$73.44$79,241.76
2026-01-141$74.11$74.11
2026-01-125,746$72.05$413,999.3
2026-01-091,271$67.40$85,665.4
2025-12-1213$67.28$874.64

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare GRBK to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.